Literature DB >> 2915981

Identification of androgen receptors in normal human osteoblast-like cells.

D S Colvard1, E F Eriksen, P E Keeting, E M Wilson, D B Lubahn, F S French, B L Riggs, T C Spelsberg.   

Abstract

The sex steroids, androgens and estrogens, are major regulators of bone metabolism. However, whether these hormones act on bone cells through direct or indirect mechanisms has remained unclear. A nuclear binding assay recently used to demonstrate estrogen receptors in bone [Eriksen, E.F., Colvard, D.S., Berg, N.J., Graham, M.L., Mann, K.G., Spelsberg, T.C. & Riggs, B.L. (1988) Science 241, 84-86] was used to identify specific nuclear binding of a tritiated synthetic androgen, [3H]R1881 (methyltrienolone), in 21 of 25 (84%) human osteoblast-like cell strains and a concentration of bound steroid receptors of 821 +/- 140 (mean +/- SEM) molecules per cell nucleus. Binding was saturable and steroid-specific. Androgen receptor gene expression in osteoblasts was confirmed by RNA blot analysis. Relative concentrations of androgen and estrogen receptors were compared by measuring specific nuclear estrogen binding. Nuclear binding of [3H]estradiol was observed in 27 of 30 (90%) cell strains; the concentration of bound estradiol receptor was 1537 +/- 221 molecules per cell nucleus. The concentrations of nuclear binding sites were similar in males and females for both [3H]R1881 and [3H]estradiol. We conclude that both androgens and estrogens act directly on human bone cells through their respective receptor-mediated mechanisms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2915981      PMCID: PMC286576          DOI: 10.1073/pnas.86.3.854

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

2.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.

Authors:  B S Komm; C M Terpening; D J Benz; K A Graeme; A Gallegos; M Korc; G L Greene; B W O'Malley; M R Haussler
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

3.  Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis.

Authors:  B L Riggs; J Jowsey; R S Goldsmith; P J Kelly; D L Hoffman; C D Arnaud
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

4.  Enhanced linear growth responses in hypopituitary dwarfs treated with growth hormone plus androgen versus growth hormone alone.

Authors:  M H MacGillivray; M Kolotkin; R W Munschauer
Journal:  Pediatr Res       Date:  1974-02       Impact factor: 3.756

5.  Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male.

Authors:  D T Baran; M A Bergfeld; S L Teitelbaum; L V Avioli
Journal:  Calcif Tissue Res       Date:  1978-12-08

6.  Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

Authors:  R Lindsay; D M Hart; J M Aitken; E B MacDonald; J B Anderson; A C Clarke
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

7.  Cloning of human androgen receptor complementary DNA and localization to the X chromosome.

Authors:  D B Lubahn; D R Joseph; P M Sullivan; H F Willard; F S French; E M Wilson
Journal:  Science       Date:  1988-04-15       Impact factor: 47.728

8.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

9.  Relationship of nuclear estrogen receptor levels to induction of ovalbumin and conalbumin mRNA in chick oviduct.

Authors:  E R Mulvihill; R D Palmiter
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

10.  Oestrogen binding proteins in bone cell cytosol.

Authors:  H C van Paassen; J Poortman; I H Borgart-Creutzburg; J H Thijssen; S A Duursma
Journal:  Calcif Tissue Res       Date:  1978-08-18
View more
  57 in total

Review 1.  Regulation of body composition by androgens.

Authors:  S Bhasin
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 2.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

3.  Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone.

Authors:  A Bojesen; N Birkebæk; K Kristensen; L Heickendorff; L Mosekilde; J S Christiansen; C H Gravholt
Journal:  Osteoporos Int       Date:  2010-07-24       Impact factor: 4.507

4.  Optimizing bone health in anorexia nervosa and hypothalamic amenorrhea: new trials and tribulations.

Authors:  Joo-Pin Foo; Ole-Petter R Hamnvik; Christos S Mantzoros
Journal:  Metabolism       Date:  2012-01-31       Impact factor: 8.694

5.  Aromatization of androgens is important for skeletal maintenance of aged male rats.

Authors:  D Vanderschueren; E Van Herck; R De Coster; R Bouillon
Journal:  Calcif Tissue Int       Date:  1996-09       Impact factor: 4.333

Review 6.  Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors.

Authors:  James C Fleet; Ryan D Schoch
Journal:  Crit Rev Clin Lab Sci       Date:  2010-08       Impact factor: 6.250

7.  Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene.

Authors:  D L S Danilovic; P H S Correa; E M F Costa; K F S Melo; B B Mendonca; I J P Arnhold
Journal:  Osteoporos Int       Date:  2006-11-01       Impact factor: 4.507

Review 8.  Androgens and bone.

Authors:  Bart L Clarke; Sundeep Khosla
Journal:  Steroids       Date:  2008-10-17       Impact factor: 2.668

9.  Androgen receptor-mediated apoptosis is regulated by photoactivatable androgen receptor ligands.

Authors:  Boris Risek; Piotr Bilski; Annette B Rice; William T Schrader
Journal:  Mol Endocrinol       Date:  2008-06-18

Review 10.  Recent experimental and clinical findings in the skeleton associated with loss of estrogen hormone or estrogen receptor activity.

Authors:  Eric P Smith; Bonny Specker; Kenneth S Korach
Journal:  J Steroid Biochem Mol Biol       Date:  2009-11-10       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.